KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Keurig Dr Pepper (KDP) Cash & Equivalents (2016 - 2025)

Keurig Dr Pepper (KDP) has disclosed Cash & Equivalents for 17 consecutive years, with $1.0 billion as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 101.18% to $1.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.0 billion, a 101.18% increase, with the full-year FY2025 number at $1.0 billion, up 101.18% from a year prior.
  • Cash & Equivalents was $1.0 billion for Q4 2025 at Keurig Dr Pepper, up from $53.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.0 billion in Q4 2025 to a low of $2.0 million in Q1 2022.
  • A 5-year average of $362.6 million and a median of $317.0 million in 2024 define the central range for Cash & Equivalents.
  • Biggest YoY gain for Cash & Equivalents was 30733.33% in 2022; the steepest drop was 99.4% in 2022.
  • Keurig Dr Pepper's Cash & Equivalents stood at $567.0 million in 2021, then dropped by 5.64% to $535.0 million in 2022, then plummeted by 51.4% to $260.0 million in 2023, then surged by 96.15% to $510.0 million in 2024, then skyrocketed by 101.18% to $1.0 billion in 2025.
  • Per Business Quant, the three most recent readings for KDP's Cash & Equivalents are $1.0 billion (Q4 2025), $53.0 million (Q3 2025), and $56.0 million (Q2 2025).